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Research
The prevalence of asthma has been rising
over the past 25 years, particularly in chil-
dren (Mannino et al. 2002). The brevity of
this time span strongly suggests that some-
thing in the environment is affecting the
development of asthma. Coincidentally,
organophosphorus pesticides were intro-
duced and have been extensively used during
this same time frame (Wessels et al. 2003).
Human exposure to organophosphorus pesti-
cides is widespread and occurs both in inner
cities, where organophosphorus pesticides are
routinely used for control of roaches and
rodents (Berkowitz et al. 2003; Landrigan
et al. 1999; Lu et al. 2001), and in rural
communities, where organophosphorus pes-
ticides are used in agriculture (Fenske et al.
2002; Koch et al. 2002; Schwartz 1999).
Humans are exposed via inhalation, absorp-
tion through skin or eyes, and ingestion
(Gallo and Lawryk 1991). Children are at
particularly high risk for exposure (Faustman
et al. 2000; Fenske et al. 1990; Gurunathan
et al. 1998; Landrigan et al. 1999) and may
retain higher concentrations of organophos-
phorus pesticide metabolites than adults
(Barr et al. 2004). Epidemiologic studies
report a positive association between organo-
phosphorus pesticide exposure and asthma in
both children (Eskenazi et al. 1999) and
adults (Deschamps et al. 1994; Hoppin et al.
2006, 2007; Senthilselvan et al. 1992).
Organophosphorus pesticides, at environ-
mentally relevant concentrations that do not
inhibit acetylcholinesterase (AChE), may pre-
cipitate asthma in humans (Bryant 1985) and
cause airway hyperreactivity, a key feature of
asthma, in guinea pigs (Fryer et al. 2004;
Lein and Fryer 2005). Under normal cir-
cumstances, airway tone is maintained by
parasympathetic nerves that release acetyl-
choline onto M3 muscarinic receptors, caus-
ing airway smooth muscle to contract.
Acetylcholine release is limited by inhibitory
M2 muscarinic receptors on parasympathetic
nerves (Fryer and Maclagan 1984). In ani-
mals exposed to low concentrations of
organophosphorus pesticides, neuronal M2
muscarinic receptor function is lost, increas-
ing release of acetylcholine and potentiating
bronchoconstriction (Fryer et al. 2004; Lein
and Fryer 2005).
Asthma and antigen challenge–induced
airway hyperreactivity are characterized by air-
way eosinophilia (Adamko et al. 2005;
Wenzel 2003). Antigen sensitization, without
challenge, causes eosinophils to cluster around
airway nerves in guinea pigs (Adamko et al.
2003), a finding also reported in human
asthma (Costello et al. 1997). Antigen inhala-
tion activates eosinophils, causing release of
major basic protein that binds to and inhibits
neuronal M2 muscarinic receptors leading to
airway hyperreactivity (Fryer and Jacoby
1992; Jacoby et al. 1993). Antigen sensitiza-
tion may also influence airway hyperreactivity
triggered by other factors. For example, viral
infection, which exacerbates asthma (Johnston
et al. 1995; Nicholson et al. 1993), causes air-
way hyperreactivity by inhibiting neuronal
M2 receptor function (Fryer and Jacoby
1991). In nonsensitized animals, virus-
induced hyperreactivity does not require the
presence of eosinophils around airway nerves
(Adamko et al. 1999); however, with sensitiza-
tion, the mechanism of virus-induced hyperre-
activity changes to become eosinophil
dependent (Adamko et al. 1999). Here we
show that prior sensitization to antigen not
only changes the mechanism of organophos-
phorus pesticide-induced airway hyperreactiv-
ity, but also increases vulnerability to
organophosphorus pesticides. 
Materials and Methods
Animals. Specific pathogen-free female
Dunkin-Hartley guinea pigs were obtained
from Elm Hill Labs (Chelmsford, MA) in
filtered crates, housed in a room with
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BACKGROUND: Recent epidemiologic studies have identified organophosphorus pesticides (OPs) as
environmental factors potentially contributing to the increase in asthma prevalence over the last
25 years. In support of this hypothesis, we have demonstrated that environmentally relevant con-
centrations of OPs induce airway hyperreactivity in guinea pigs. 
OBJECTIVES: Sensitization to allergen is a significant contributing factor in asthma, and we have
shown that sensitization changes virus-induced airway hyperreactivity from an eosinophil-indepen-
dent mechanism to one mediated by eosinophils. Here, we determine whether sensitization simi-
larly influences OP-induced airway hyperreactivity. 
METHODS: Nonsensitized and ovalbumin-sensitized guinea pigs were injected subcutaneously with
the OP parathion (0.001–1.0 mg/kg). Twenty-four hours later, animals were anesthetized and ven-
tilated, and bronchoconstriction was measured in response to either vagal stimulation or intra-
venous acetylcholine. Inflammatory cells and acetylcholinesterase activity were assessed in tissues
collected immediately after physiologic measurements.
RESULTS: Ovalbumin sensitization decreased the threshold dose for parathion-induced airway
hyperreactivity and exacerbated parathion effects on vagally induced bronchoconstriction.
Pretreatment with antibody to interleukin (IL)-5 prevented parathion-induced hyperreactivity in
sensitized but not in nonsensitized guinea pigs. Parathion did not increase the number of
eosinophils in airways or the number of eosinophils associated with airway nerves nor did it alter
eosinophil activation as assessed by major basic protein deposition.
CONCLUSIONS: Antigen sensitization increases vulnerability to parathion-induced airway hyperreac-
tivity and changes the mechanism to one that is dependent on IL-5. Because sensitization to aller-
gens is characteristic of 50% of the general population and 80% of asthmatics (including children),
these findings have significant implications for OP risk assessment, intervention, and treatment
strategies.
KEY WORDS: airway hyperreactivity, asthma, atopy, eosinophils, organophosphorus pesticides,
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high-efficiency particulate-filtered air, and fed
a normal diet (Prolab; Agway, Syracuse, NY).
We chose guinea pigs for these studies because
their lung pharmacology is similar to humans
(Canning 2003). In addition, organophospho-
rus pesticides uniformly cause airway hyper-
reactivity in guinea pigs unlike mice, which
respond differently depending upon the strain
(Smolen et al. 1985, 1986). All guinea pigs
were treated humanely with regard for allevia-
tion of suffering in accordance with the stan-
dards established by the U.S. Animal Welfare
Act as set forth in the National Institutes of
Health guidelines (NIH 2002). All protocols
involving guinea pigs were approved by the
Animal Care and Use Committee at Oregon
Health & Science University. 
Ovalbumin sensitization. Guinea pigs
(150–200 g) received 3 ip injections of oval-
bumin (Sigma-Aldrich Chemical Co., St.
Louis, MO) at 6 mg/kg body weight (bw) in
sterile phosphate-buffered saline (PBS) on
days 1, 3, and 5 (Adamko et al. 1999). Other
treatments were not given until 21 days after
the last injection of ovalbumin. 
Parathion exposure. Parathion (o,o-diethyl-
o-p-nitrophenyl phosphorothioate, 99.5%
pure) was purchased from Chem Service, Inc.
(West Chester, PA). Parathion was suspended
in peanut oil, and doses of 0.001–1.0 mg/kg
bw or equal volumes of peanut oil (300 µL)
were injected sc into the subscapular region
(Lein and Fryer 2005). This route of exposure
allows for steady release of pesticides, as
observed in human exposure (Pope et al.
1991). Peanut oil was administered to controls.
After parathion injections, animals were moni-
tored (1, 4, and 24 hr) for signs of cholinergic
intoxication (tremors, altered gait, and exces-
sive excretions), which were not observed with
any of the doses used in this study. A 10-fold
higher concentration of parathion has been
used in guinea pigs (Lein and Fryer 2005)
without any ill-effects on their health.
Physiologic measurements of lung function
were performed 24 hr after injection.
AbIL5. Interleukin (IL)-5 is required for
eosinophil maturation, and antibody to IL-5
(AbIL5) was previously shown to deplete
eosinophils and prevent airway hyperreactiv-
ity in antigen-challenged guinea pigs (Elbon
et al. 1995). Monoclonal AbIL5 (TRFK-5)
was purchased from BD Pharmingen (San
Diego, CA), diluted in sterile PBS to a con-
centration of 240 µg/kg bw, and administered
ip 4 days before physiologic measurements of
lung function. An equal volume of PBS was
administered to control animals. 
Anesthesia and measurement of pulmonary
inflation pressure (Ppi). We performed physio-
logic experiments as previously described
(Fryer and Jacoby 1992). All guinea pigs were
young adults weighing between 340–410 g at
the time of testing lung physiology. Guinea
pigs were anesthetized with 1.5–1.9 g/kg bw
urethane, ip (Sigma-Aldrich Chemical Co.).
This concentration of urethane provides anes-
thesia for 8 hr, and experiments did not extend
past 4 hr. Jugular veins were cannulated for
drug administration, and one carotid artery
was cannulated to monitor blood pressure and
heart rate. Both vagus nerves were cut and
placed on electrodes submerged in oil for vagal
stimulation. Guinea pigs were mechanically
ventilated via a tracheal cannula providing a
positive pressure and constant volume
(1 mL/100 g bw and 100 breaths/min).
Animals were given guanethidine (2 mg/kg
bw, iv; Sigma-Aldrich Chemical Co.) to
deplete noradrenaline and were paralyzed with
succinylcholine (10 µg/kg/min, iv; Sigma-
Aldrich Chemical Co.) throughout the experi-
ment. Pulmonary inflation pressure was
measured on a side arm of the tracheal can-
nula. Bronchoconstriction was measured as an
increase in pulmonary inflation pressure (in
mmH2O) over the ventilator baseline pressure
as previously described (Fryer and Maclagan
1984; Fryer and Wills-Karp 1991; Jacoby and
Fryer 1991). Vagus nerves were stimulated at
1-min intervals (2–15 Hz, 10 V, 0.2 msec
square waves, 5-sec train duration). 
Measurement of postjunctional M2 and
M3 muscarinic receptor function. We admin-
istered acetylcholine iv (1–10 µg/kg bw; Acros
Organics, Morris Plains, NJ) to test the func-
tion of postjunctional M2 muscarinic recep-
tors in cardiac muscle and postjunctional M3
muscarinic receptors on airway smooth mus-
cle. In these experiments, we cut the vagus
nerves to eliminate reflex-induced broncho-
constriction (Wagner and Jacoby 1999).
Bronchoalveolar lavage. After physiologic
measurements in control and parathion-treated
guinea pigs, 50 mL warm PBS containing
10 µg/mL isoproterenol (Sigma-Aldrich
Chemical Co.) was flushed through the tracheal
cannula and retrieved by syringe in 10-mL
aliquots. Cells were washed and resuspended in
10 mL PBS and counted on a hemocytometer
(for total cell counts). Cells were also cytospun
onto slides and stained with Hemacolor (EMD
Chemicals, Inc., Gibbstown, NJ) to obtain dif-
ferential counts of macrophages, eosinophils,
neutrophils, and lymphocytes. 
Histology. Lungs were perfused with PBS
via the pulmonary artery, removed, and
inflated with 10 mL zinc formalin (Anatech
Ltd., Battle Creek, MI). Two transverse sec-
tions of the proximal region of two lobes
(3–5 mm) were embedded in paraffin and
processed for immunohistochemistry. Airway
nerves were detected with an Ab specific for
PGP 9.5 (Cat. no. 7863-2004; Biogenesis,
Poole, England) and eosinophils were stained
using chromotrope 2R (C-3143; Sigma-
Aldrich Chemical Co.), as previously described
(Evans et al. 2001). Light microscopic images
were acquired using a video microscope
(CoolSnap; PhotoMetrics, Inc., Huntington
Beach, CA) and analyzed using Metamorph
Imaging System (Universal Imaging Corp.,
Downingtown, PA). We took consecutive
images around four medium-sized airways for
each animal. Eosinophils in the airway, includ-
ing the submucosal region and airway smooth
muscle and those associated within 8 µm of
nerves (the average diameter of an eosinophil)
were counted (per square millimeter airway)
and averaged for that animal. 
Major basic protein was labeled with a rab-
bit anti-guinea pig antibody (a generous gift
from G.J. Gleich, University of Utah) and
detected with Alexa Flour 594 goat anti-rabbit
IgG secondary antibody (#A11012; Molecular
Probes, Eugene, OR). Consecutive images were
taken around four cartilaginous airways for each
animal, focusing on smooth muscle and con-
nective tissue immediately surrounding the air-
way. Slides were analyzed by an independent
observer blinded to the experimental condi-
tions. An image with the most intense fluores-
cence was used to establish the exposure time
used for all other images. A 100 × 100 pixel
region within the lumen of the airway of each
photograph was used to determine background
fluorescence. A slide that was not reacted with
antibody to major basic protein was used to
determine the lower threshold for excluding
nonspecific staining. Using Metamorph soft-
ware (Molecular Devices, Sunnyvale, CA), we
adjusted image threshold to measure only extra-
cellular major basic protein (to exclude
eosinophils). Average fluorescence per area was
tabulated for each airway and then averaged for
each animal. 
AChE assay. We collected heparinized
blood, brain, and PBS-perfused lung to meas-
ure AChE activity using the Ellman assay
(Ellman et al. 1961), as previously described
(Lein and Fryer 2005). 
Statistics. We analyzed a minimum of
three to four guinea pigs, but more typically
five to seven were analyzed per experimental
condition. The effects of sensitization and
parathion on baseline body weight, pulmonary
inflation pressure, blood pressure, and heart
rate were analyzed by one-way analysis of vari-
ance (ANOVA) analysis using the Bonferroni
correction. We compared bronchoconstriction
in response to vagal stimulation and to intra-
venous acetylcholine, using two-way ANOVA
for repeated measures. Changes in AChE
activity, leukocytes in bronchoalveolar lavage
fluid, and eosinophils in airways were analyzed
by one-way ANOVA analysis using the Fisher
least significant difference post hoc test. All
values are expressed as the mean ± SE.
Results
Baseline physiologic parameters. Nonsensitized
and ovalbumin-sensitized guinea pigs were age
Proskocil et al.
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matched. Sensitized animals were not chal-
lenged with antigen prior to experimentation.
Guinea pig weight (360 ± 11 g in nonsensi-
tized vs. 405 ± 14 g in sensitized animals),
baseline pulmonary inflation pressure
(100 ± 6 mmH2O in nonsensitized vs.
89 ± 3 mmH2O in sensitized animals), heart
rate (325 ± 11 beats/min in nonsensitized vs.
286 ± 7 beats/min in sensitized animals), and
blood pressure (51 ± 3 systolic/25 ± 2 diastolic
mmHg in nonsensitized vs. 45 ± 2 systolic/
23 ± 1 diastolic mmHg in sensitized animals)
were not changed by parathion treatment. 
Bronchoconstriction. Electrical stimula-
tion of both vagus nerves caused frequency-
dependent bronchoconstriction that was not
significantly altered by sensitization to oval-
bumin (Figure 1). In nonsensitized animals,
doses of parathion ≥ 0.01 mg/kg bw potenti-
ated vagally induced bronchoconstriction
(Figure 1). This potentiation was significantly
enhanced by prior sensitization to ovalbumin.
Additionally, low doses of parathion
(0.001 mg/kg bw) that had no effect on
vagally induced bronchoconstriction in non-
sensitized animals increased vagally induced
bronchoconstriction in guinea pigs that had
been sensitized to ovalbumin (Figure 1, light
blue triangles). Thus, parathion-induced
hyperreactivity is exacerbated by sensitization.
In addition, sensitization decreases the thresh-
old dose of parathion needed to cause airway
hyperreactivity. 
Parathion-induced airway hyperreactivity
was prevented by pretreatment with AbIL5 in
sensitized but not in nonsensitized guinea pigs
(Figure 2). In the absence of parathion, AbIL5
did not have any effect on vagally induced
bronchoconstriction (Figure 2, blue circles).
Intravenous acetylcholine administered to
vagotomized animals caused dose-dependent
bronchoconstriction that was not altered by
sensitization or by parathion (Figure 3).
Bradycardia. Vagal stimulation caused
frequency-dependent bradycardia that was
not affected by sensitization (Figure 4A).
Parathion slightly, but not significantly,
potentiated vagally induced bradycardia in
nonsensitized guinea pigs, and this response
was not altered by sensitization (Figure 4A) or
by pretreatment with AbIL5 (Figure 4B).
Neither sensitization nor parathion affected
acetylcholine-induced bradycardia (Figure 5). 
AChE activity. Sensitization alone signifi-
cantly increased AChE activity in lung; how-
ever, at the doses tested in this study,
parathion did not inhibit AChE activity in
brain, lung, or blood in either nonsensitized
or sensitized guinea pigs (Figure 6). 
Bronchoalveolar lavage. Total inflamma-
tory cells in bronchoalveolar lavage fluid were
significantly increased by sensitization
(9 ± 1.3 million cells in nonsensitized versus
13 ± 1.2 million cells in sensitized animals,
p < 0.05). Neither parathion (0.001–1 mg/kg
bw, sc) nor AbIL5 altered total cells recovered
from either nonsensitized or sensitized animals
(data not shown). A comparative analysis of
macrophages, neutrophils, lymphocytes, and
eosinophils indicates that the increase in total
cells observed in sensitized guinea pigs pri-
marily reflects an increase in eosinophils (data
Sensitization alters OP-induced hyperreactivity
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Figure 1. Parathion (Pth) potentiates vagally stimulated bronchoconstriction in nonsensitized (A) and sen-
sitized (B) guinea pigs. Electrical stimulation of both vagus nerves (2–15 Hz, 10 V, 0.2 msec, 5-sec pulse
train) caused frequency-dependent bronchoconstriction as measured by an increase in Ppi. Vagally
induced bronchoconstriction was not significantly different in nonsensitized control and sensitized control
animals. In nonsensitized animals, 0.01 mg/kg bw, 0.1 mg/kg bw, and 1.0 mg/kg bw parathion sc signifi-
cantly increased vagally induced bronchoconstriction, whereas 0.001 mg/kg bw parathion sc had no
effect. In sensitized animals, 0.1 mg/kg bw and 1.0 mg/kg bw parathion sc significantly increased vagally
induced bronchoconstriction; 0.001 mg/kg bw parathion sc also increased vagally induced bronchocon-
striction in sensitized guinea pigs, although this change did not reach statistical significance. The increase
in vagally induced bronchoconstriction in response to 0.1 mg/kg bw and 1.0 mg/kg bw parathion sc was
significantly greater in sensitized animals than in nonsensitized animals. Data are presented as mean ± SE
(n = 3–13 guinea pigs).
*p < 0.05 compared with similar treatment in nonsensitized animals. **p < 0.05 compared with respective control animals. 
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Figure 2. Differential effects of AbIL5 on parathion (Pth) potentiation of vagally -induced bronchoconstric-
tion in nonsensitized (A) versus sensitized (B) animals. Electrical stimulation of the vagus nerves caused
frequency-dependent bronchoconstriction, and responses in control and 1.0 mg/kg bw parathion-treated
guinea pigs are graphed as in Figure 1. AbIL5 (240 µg/kg bw, ip) given prior to 1.0 mg/kg bw parathion did not
protect parathion-induced airway hyperreactivity in nonsensitized guinea pigs but did in sensitized guinea
pigs. AbIL5 alone did not affect airway reactivity. Data are presented as mean ± SE (n = 4–13 guinea pigs).
*p < 0.05 compared with similar treatment in nonsensitized animals; **p < 0.05 compared with respective control animals.
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not shown). Treatment with AbIL5 decreased
eosinophils in sensitized guinea pigs (3.7 ±
0.95 × 106 eosinophils vs. 1.8 ± 0.55 × 106
eosinophils in animals treated with AbIL5).
In sensitized animals, the two higher doses of
parathion decreased eosinophils in the lavage,
although this was not statistically significant
(Figure 7). Other inflammatory cells were not
affected by parathion in sensitized guinea pigs
(data not shown). In nonsensitized guinea
pigs, parathion had no effect on eosinophils
(Figure 7) or other inflammatory cell popula-
tions (data not shown). 
Airway histology. Because parathion
decreased eosinophils in the lavage of sensi-
tized animals, we examined airway histology
to determine whether eosinophils remained in
lung tissue. In sensitized guinea pigs, neither
parathion nor AbIL5 affected eosinophils in
airway tissues or eosinophils associated with
nerves (Figure 8). In nonsensitized guinea
pigs, parathion decreased eosinophils in air-
way tissues as well as in eosinophils specifi-
cally associated with airway nerves (Figure 8). 
Eosinophil degranulation. Because
parathion decreased eosinophils in the lavage
of sensitized animals but did not similarly
affect eosinophils in airway tissues, extracellular
major basic protein deposition was quantified
as an indicator of eosinophil degranulation.
Sensitization significantly increased major basic
protein deposition in the lungs. Although
parathion had no effect on major basic protein
deposition in nonsensitized animals, it signifi-
cantly decreased major basic protein deposition
in sensitized animals (Figure 9). 
Discussion
The data presented here show that in adult
female guinea pigs, sensitization to allergen
increases vulnerability to organophosphorus
pesticide-induced airway hyperreactivity. The
organophosphorus pesticide parathion poten-
tiated vagally induced bronchoconstriction in
nonsensitized guinea pigs as previously shown
(Fryer et al. 2004; Lein and Fryer 2005).
Sensitization to ovalbumin decreased the
threshold dose of parathion required to cause
airway hyperreactivity and exacerbated
parathion potentiation of vagally induced
bronchoconstriction. In addition, administra-
tion of AbIL5 before parathion blocked
parathion-induced airway hyperreactivity in
sensitized but not in nonsensitized guinea
pigs. Thus, sensitization increases the ability
of organophosphorus pesticides to cause air-
way hyperreactivity and also changes the
mechanism from IL-5 independent to IL-5
dependent. 
It has been proposed that organophospho-
rus pesticide–induced asthma is mediated by
inhibition of AChE (Senthilselvan et al.
1992), the enzyme that degrades acetyl-
choline. Antigen sensitization alone increased
Proskocil et al.
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Figure 4. Parathion (Pth) potentiation of vagally induced bradycardia is not changed by sensitization.
Electrical stimulation of both vagi (2–15 Hz, 10 V, 0.2 msec, 5-sec pulse train) caused frequency-dependent
bradycardia. (A) Parathion slightly but not significantly increased vagally induced bradycardia in both non-
sensitized and sensitized animals. In contrast to the lung, however, sensitization did not exacerbate
parathion effects. (B) AbIL5 did not affect vagally induced bradycardia in either nonsensitized or sensitized
animals. Data are presented as mean ± SE (n = 3–12 guinea pigs).
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AChE activity in lungs. This does not agree
with other reports that sensitization decreases
AChE activity in tracheal smooth muscle
(Mitchell et al. 1991, 1992). We have shown
that sensitization of guinea pigs increases
eosinophils in the lungs. Inflammatory cells
(Kawashima and Fujii 2000), including
eosinophils (Lepore et al. 1984), express
AChE activity, and there is evidence that
eosinophils can induce AChE RNA expression
and activity in a neuroblastoma cell line
(Durcan et al. 2006). Although there was an
increase in AChE activity in the whole lungs
of sensitized guinea pigs, this did not affect
airway physiology, as both nonsensitized and
sensitized guinea pigs had similar increases in
bronchoconstriction in response to vagal stim-
ulation (Figure 1). Parathion did not inhibit
AChE activity in either nonsensitized or sensi-
tized guinea pigs. Moreover, bronchoconstric-
tion in response to exogenous acetylcholine
was not increased by parathion treatment.
Together, these data demonstrate that the
increased response to vagal stimulation in
parathion-treated animals was due to increased
acetylcholine release, and not to inhibited
AChE activity or increased sensitivity of
smooth muscle. Thus, parathion selectively
targets nerve function to potentiate vagally
induced bronchoconstriction. 
Although some eosinophils reside in nor-
mal guinea pig lungs, sensitization without
antigen challenge is sufficient to recruit addi-
tional eosinophils to the lungs (Adamko et al.
1999). Eosinophil presence alone, however, is
not sufficient to cause airway hyperreactivity
(Adamko et al. 1999, 2003); they must be
activated by subsequent antigen challenge
(Costello et al. 1997, 2000; Kingham et al.
2003) or viral infection (Adamko et al. 1999,
2003). Thus, it is not the presence of
eosinophils in lung but the presence of acti-
vated eosinophils around airway nerves that
correlates with airway hyperreactivity (Costello
et al. 1997, 2000; Kingham et al. 2003). 
Organophosphorus pesticides cause a loss
of parasympathetic prejunctional M2 mus-
carinic receptor function (Fryer et al. 2004;
Lein and Fryer 2005). Loss of neuronal M2
muscarinic receptor function in antigen-chal-
lenged guinea pigs results from binding of
major basic protein, an endogenous M2 mus-
carinic receptor antagonist released from acti-
vated eosinophils (Evans et al. 1997; Jacoby
et al. 1993). Therefore, it was surprising to
find that parathion did not increase eosinophil
recruitment to the lungs or to the nerves.
Decreased eosinophils may result from activa-
tion and degranulation as measured by major
basic protein deposition (Verbout et al. 2007).
Although low concentrations of organophos-
phorus pesticides can degranulate mast cells
and basophils (Rodgers and Ellefson 1992;
Rodgers and Xiong 1997; Xiong and Rodgers
1997), parathion did not increase eosinophil
activation in the lungs as measured by deposi-
tion of major basic protein. 
Sensitization changes the mechanism 
by which parathion causes airway hyperreactiv-
ity to become IL-5 dependent. The ability 
of sensitization to switch the mechanisms of
inflammation to be IL-5 dependent has been
reported in mice. Viral infection of mice nor-
mally increases interferon but not IL-5,
whereas viral infection of sensitized mice
increases IL-5 but not interferon (Coyle et al.
1995). Similar results have been found in
guinea pigs that have been sensitized prior to
Sensitization alters OP-induced hyperreactivity
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Figure 5. Acetylcholine-induced bradycardia does not differ with either parathion (Pth) exposure or sensiti-
zation. Bradycardia induced by increasing doses of exogenous acetylcholine (1–10 µg/kg bw, iv) was meas-
ured in nonsensitized (A) and sensitized (B) guinea pigs exposed to parathion or vehicle. All animals were
vagotomized prior to administration of acetylcholine. Data presented as mean ± SE (n = 3–13 guinea pigs).
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Figure 6. Doses of parathion (Pth; mg/kg bw) that cause hyperreactivity do not inhibit AChE. Neither
parathion nor sensitization inhibited AChE activity in the lung (A, nonsensitized; B, sensitized), blood (C,
nonsensitized; D, sensitized), or brain (E, nonsensitized; F, sensitized) of guinea pigs. However, in lung,
sensitization increased AChE activity. Data are presented as mean ± SE (n = 3–17 guinea pigs).
*p < 0.005.
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viral infection (Adamko et al. 2003). Although
IL-5 is a key regulator for eosinophil recruit-
ment and activation (Lopez et al. 1988;
Yamaguchi et al. 1988), IL-5 receptors are pre-
sent on other inflammatory cells (Dewachi
et al. 2006; Pierrot et al. 2001; Suttmann et al.
2003). Although we have yet to establish a
clear role for eosinophils or other inflammatory
cells in parathion-induced hyperreactivity, our
data show that sensitization changes the mech-
anism of parathion-induced hyperreactivity
from IL-5 independent to IL-5 dependent. 
One possible mechanism underlying
potentiation of airway hyperreactivity by
parathion in sensitized animals may involve
paraoxonase, the enzyme that degrades the
active metabolite of parathion. Inflammation
decreases paraoxonase activity (Cabana et al.
1996; Van Lenten et al. 1995), which would
be expected to increase the biological half-life
of the active parathion metabolite. Whether
the decrease of paraoxonase activity by inflam-
mation requires eosinophils is not known, but
if this were the case, it would explain the
requirement for IL-5 in parathion-induced
hyperreactivity in sensitized animals. The
mechanism by which parathion causes airway
hyperreactivity in nonsensitized guinea pigs is
currently under investigation. Organo-
phosphorus pesticides down-regulate or com-
petitively bind to muscarinic receptors in
brain [as reviewed by Jett and Lein (2007)],
and by analogy, organophosphorus pesticides
may interact directly with neuronal M2 recep-
tors to block their function and increase
vagally induced acetylcholine release from
parasympathetic nerves, thus potentiating
vagally induced bronchoconstriction. 
As in the lungs, all doses of parathion
slightly shifted vagally induced bradycardia to
the right, although the effect was not dose
related or significant. This minor shift has been
reported before (Lein and Fryer 2005) and
occurred regardless of sensitization status or
AbIL5 treatment. This parathion-mediated
shift in vagally induced bradycardia may be
due to selective loss of neuronal M2 muscarinic
receptor function on parasympathetic nerves
supplying the heart. Because acetylcholine-
induced bradycardia, which is mediated by
postjunctional M2 receptors, was not altered
by parathion, this suggests that prejunctional
and postjunctional M2 muscarinic receptors
are regulated independently in different tissues.
A similar susceptibility of neuronal M2
Proskocil et al.
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Figure 7. Eosinophils from bronchoalveolar lavage are affected by sensitization and parathion (Pth; mg/kg
bw). (A) In nonsensitized guinea pigs, eosinophils in the bronchoalveolar lavage were not affected by
parathion. (B) Sensitization significantly increased eosinophils, and 0.1 mg/kg bw and 1.0 mg/kg bw
parathion reduced eosinophils in bronchoalveolar lavage, although this effect was not statistically signifi-
cant. AbIL5 inhibited eosinophils recovered in the bronchoalveolar lavage of sensitized guinea pigs (3.7 ±
0.95 × 106 eosinophils versus 1.8 ± 0.55 × 106 eosinophils in animals treated with AbIL5). Data presented as
mean ± SE (n = 3–17 guinea pigs).
*p < 0.05. 
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Figure 8. Quantification of eosinophils in lungs and along airway nerves. Abbreviations: BEC, bronchial epithelial cells; L, lumen; N, nerve; Pth, parathion; SM,
smooth muscle. (A) Representative images of airways from nonsensitized and sensitized, control, and 1.0-mg/kg bw parathion-treated guinea pigs (scale bar =
100 µm). Airway nerves (N) were immunolabeled for PGP 9.5 (purple–black staining) and eosinophils were stained red with chromotrope 2R. Eosinophils associ-
ated with airway nerves are indicated by an arrowhead (A). In nonsensitized guinea pigs, parathion decreased eosinophils in peribronchial regions (B) and
around airway nerves (C). Sensitization did not change the number of eosinophils in the airway (B) nor did parathion have an effect on the number of eosinophils
in airways (B) or along airway nerves (C) in sensitized guinea pigs.
+p < 0.05 compared with respective control animals (n = 4–7 guinea pigs).
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Figure 9. Quantification of eosinophil major basic
protein in lung tissue. Extracellular major basic pro-
tein was quantified by fluorescent immunohisto-
chemistry in peribronchial regions. In nonsensitized
guinea pigs, parathion (Pth; 1.0 mg/kg bw sc) did
not cause an increase in major basic protein depo-
sition. Sensitization significantly increased major
basic protein deposition, an effect that was attenu-
ated by 1.0 mg/kg bw parathion. Data presented as
mean ± SE (n = 3–5 guinea pigs).
*p < 0.05 compared with similar treatment in nonsensitized
animals. **p < 0.05 compared with respective control. 
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muscarinic receptors has been reported in
guinea pigs treated with double-stranded RNA
(Bowerfind et al. 2002). Whether susceptibility
of neuronal receptors is mediated by lack of
spare receptors or differences in local cellular
environments is not known. 
In humans, airway hyperreactivity may be
subtle and not noticed until measured in a
laboratory setting (Empey et al. 1976). In
contrast to our guinea pig model, human
exposure to allergens and to pesticides is
diverse and airway response to these environ-
mental factors can be influenced by genetic
background, environmental history, and age
of exposure. For example, atopic women not
born on farms but who move to a farm and
are exposed to pesticides are more likely to
develop atopic asthma than atopic women
born on farms and exposed to pesticides
(Hoppin et al. 2007). The Hoppin et al.
study demonstrates that both atopic status
and pesticide exposure in humans can impact
the development of asthma.
The results of this study confirm and
extend previous studies identifying organo-
phosphorus pesticides as environmental factors
that contribute to asthma by demonstrating
that sensitization changes the mechanism
underlying organophosphorus pesticide-
induced hyperreactivity and increases vulnera-
bility to organophosphorus pesticides. When
considered in light of data that estimate over
50% of the U.S. population is sensitized to
allergen (Arbes et al. 2005), our findings sug-
gest that allergen sensitization is a major sus-
ceptibility factor for asthma that interacts
synergistically with organophosphorus pesti-
cides. Recent studies of humans (Almqvist
et al. 2008), mice (Card et al. 2007; Carey
et al. 2007; Dimitropoulou et al. 2005; Riffo-
Vasquez et al. 2007), and guinea pigs (Regal
et al. 2006) suggest that sex hormones modify
airway responsiveness to various stimuli.
Whether sex hormones also influence
organophosphorus pesticide-induced airway
hyperreactivity remains to be determined.
Nonetheless our current work has implications
for assessing the risks associated with exposure
to organophosphorus pesticides in terms of
identifying sensitive subpopulations and set-
ting exposure limits. It also underscores the
need for further studies in order to better
understand the mechanisms mediating
organophosphorus pesticide-induced airway
hyperreactivity in allergic versus nonallergic
individuals to determine the need for develop-
ing customized prevention and therapeutic
strategies based on sensitization status.
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